Key result
Combination chemotherapy with imatinib and sirolimus led to disease stabilization and clinical improvement in 100% (3/3) of patients with severe pulmonary vein stenosis.
Why the study?
Severe pulmonary vein stenosis is often resistant to catheterization and surgical interventions and is frequently fatal, necessitating alternative therapeutic options.
Does combination chemotherapy with imatinib and sirolimus improve clinical outcomes in patients with severe primary pulmonary vein stenosis?
Case Report (n=3)
Does combination chemotherapy with imatinib and sirolimus improve clinical outcomes in patients with severe primary pulmonary vein stenosis?
Combination chemotherapy with imatinib and sirolimus shows promise as a therapeutic option for severe, progressive primary pulmonary vein stenosis.
Pulmonary vein stenosis results from a proliferative process that leads to the progressive obstruction of venous return to the left atrium. It is often resistant to catheterization and surgical based interventions and is frequently fatal when encountered in its severe form. Here, we describe three patients with severe, primary pulmonary vein stenosis that was progressing despite aggressive conventional management strategies. All three patients were initiated on combination chemotherapy with imatinib and sirolimus, drugs which have been previously shown to independently have potential benefit against PVS. Soon after the initiation of these therapies, all three patients experienced a stabilization of their disease process and clinical improvement. All three patients remain alive, with tolerable side effects from the medications. Although early in our experience and with only a small number of patients, combination chemotherapy with imatinib and sirolimus shows promise and merits further investigation as a therapeutic option for this aggressive disease.
No takes yet. Share an insight, caveat, or question.
Krivenko et al. (2023) conducted a case report in Severe, primary pulmonary vein stenosis (n=3). Combination chemotherapy with imatinib and sirolimus was evaluated on Disease stabilization and clinical improvement. Combination chemotherapy with imatinib and sirolimus led to disease stabilization and clinical improvement in 100% (3/3) of patients with severe pulmonary vein stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: